Press releases & News
Volv Global Gold Sponsor at the World AI Congress - London O2 January 30 & 31 2018
Creating New Markets with A.I. We help customers create new ways to provide treatments that reach more patients and at lower cost than has been achieved before. State of the art Data Science & Machine Learning for Healthcare & Lifesciences.
December 12th, 2017Volv will be speaking at the Artifical Intelligence in Pharma Industry Summit, February 19/20 2018, Berlin, Germany
Artificial Intelligence and Legal Responsibility - Why should we be concerned about the legal, policy, and ethical issues of AI?
October 11th, 2017Kristin Glass to Speak at the IEEE
Look out for updates on our next sessions at IEEE this year. Coming soon...
January 12th, 2018Join us in April 25/26 in Londom at the Global Clinical Trials Connect 2018
The Global Clinical Trials Connect 2018 conference focuses on introducing pioneer technology, developing better patient engagement and collaborating strategies in clinical trials...
January 18th, 2018Strategic partners
-
We make mobile security easy to adopt, easy to manage, and available on any device. Blue Cedar is pleased to work with Volv as a strategic partner in the delivery of secure patient data to mutual customers through the Blue Cedar and Volv's mHealthSecure platforms.
Read more -
PHARMO Institute for Drug Outcomes Research
PHARMO Institute for Drug Outcomes Research uses patient-centric data to derive real-life insights into value of medicines for the individual patients.
Pharmo Institute -
MediBioSense
MediBioSense Ltd are award winning digital solutions innovators for healthcare. Their cutting edge applications and wearable technology are part of the future in healthcare.
MediBioSense
Challenges
The challenges we have set ourselves
Optimise spend in R&D
The challenge is to identify reasons for extraordinary wasted spend in R&D on dead-end research and ways to reduce it. We are bringing to market a solution to this extremely compelling problem for our customers. Using advanced predictive technologies, unassisted machine learning, artificial intelligence paradigms and web-scale technologies we are building a platform to solve the problem. We are working with customers that desire to significantly reduce their dead-end research spend. We also want to work with customers who want to invest in new research using our methodology for the early identification of medical breakthroughs.
Read moreReducing healthcare costs
We have identified this as a priority area for volv. We are initially working on two specific areas to solve that will have a massive impact on overall healthcare spend. We are looking for progressive thinking governments and industry leaders to move our thinking forward.
Read moreImproving patient satisfaction
Our challenge is around reducing the impact on patients from adverse events and non-adherence. We have launched a product in March 2017 with a specific focus on web monitoring, social listening and literature search. We are looking for clients that want to progress in RWE, secure mobile patient data, rare disease, adherence and medicines and device safety agendas.
Read more